Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma

Scandinavian Journal of Urology
Gigja GuðbrandsdottirChristian Beisland

Abstract

The aim of this study was to determine whether concentrations of vascular endothelial growth factor (VEGF) in blood taken preoperatively can predict subtype, survival and recurrence in patients with renal cell carcinoma (RCC). The patient group consisted of 124 patients with an RCC that was surgically removed with nephrectomy or nephron-sparing surgery at Haukeland University Hospital from 2007 to 2010. All subtypes and stages were included. Preoperative blood samples were taken on the day of surgery, and the samples were prepared and frozen at -80 °C. The level of VEGF in serum was analysed using Luminex® immunobead technology. The patients were followed until death or to 31 October 2014 (>4.5 years). Patients with higher levels of VEGF were more likely to have clear cell RCC [odds ratio (OR) 2.43, p = 0.046], as were older patients (OR 1.04, p = 0.024). In a multivariate analysis, high VEGF, stage and nuclear grade all had a significant predictive value for cancer-specific survival (OR 4.56, p = 0.017; OR 11.54, p < 0.001; and OR 7.85, p = 0.015, respectively). VEGF, stage and nuclear grade predicted recurrence in patients presumed to have been radically treated (OR 4.37, p = 0.03; OR 5.02, p = 0.011; and OR 6.57, p = 0.008, ...Continue Reading

References

Oct 1, 1982·The American Journal of Surgical Pathology·S A FuhrmanC Limas
Dec 22, 1999·The Journal of Urology·J JacobsenB Ljungberg
Jun 5, 2004·The Oncologist·Napoleone Ferrara
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvie NegrierUNKNOWN Groupe Francais d'Immunotherapie
Dec 8, 2007·Expert Review of Anticancer Therapy·Saby George, Ronald M Bukowski
Jan 24, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Napoleone Ferrara
Jan 27, 2009·Journal of Surgical Oncology·Frederick L Greene, Leslie H Sobin
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Sep 19, 2009·Biochimica Et Biophysica Acta·Felix S GrünewaldKurt Ballmer-Hofer
Mar 5, 2011·The Oncologist·David S FinleyArie S Belldegrun
Mar 11, 2011·Critical Reviews in Oncology/hematology·Alessandro SciarraVincenzo Gentile
Jul 12, 2011·European Urology·Eirikur GuðmundssonUNKNOWN Swedish Kidney Cancer Quality Register Group
Jul 12, 2011·European Urology·Börje LjungbergLambertus A Kiemeney
Aug 10, 2012·Physiology·Michael Simons
Aug 3, 2013·The Journal of Clinical Investigation·Jonathan WeltiPeter Carmeliet

❮ Previous
Next ❯

Citations

Feb 16, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Maj RabjergNiels Marcussen
Jun 9, 2017·Technology in Cancer Research & Treatment·Jia-Quan ZhouCong-Jie Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.